Skip to main content
Premium Trial:

Request an Annual Quote

OvaGene Opens Clinical, Research Lab

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – OvaGene Oncology today announced the opening of its new clinical and research laboratory in Irvine, Calif., where the company is headquartered.

The facility will serve as the central headquarter for operations, research, and molecular clinical lab testing, OvaGene said in a statement. Technologies used for genomic testing on cancer cells at the facility include qPCR, comparative genomic hybridization, and gene expression arrays.

OvaGene is in the process of pursuing clinical laboratory licensure and accreditation. If it is successful, the company will offer molecular diagnostics to the gynecological community, it said. In addition, the company will develop diagnostics based on in-licensed technologies and internal research. The research will include collaborations with pharma firms in the oncology space in order to develop companion diagnostics.

OvaGene develops and commercializes personalized DNA-based diagnostics for gynecologic cancer.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.